{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:04:00Z","timestamp":1791291840093,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,2,17]],"date-time":"2009-02-17T00:00:00Z","timestamp":1234828800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s00406-009-0868-5","type":"journal-article","created":{"date-parts":[[2009,2,17]],"date-time":"2009-02-17T10:25:41Z","timestamp":1234866341000},"page":"284-292","source":"Crossref","is-referenced-by-count":46,"title":["Psychomotor performance in relation to acute oral administration of \u03949-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects"],"prefix":"10.1007","volume":"259","author":[{"given":"Patrik","family":"Roser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Gallinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Juckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Gorynia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas M.","family":"Stadelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,17]]},"reference":[{"key":"868_CR1","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","volume":"2","author":"S Andreasson","year":"1987","unstructured":"Andreasson S, Allebeck P, Engstrom A, Rydberg U (1987) Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 2:1483\u20131486","journal-title":"Lancet"},{"key":"868_CR2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","volume":"134","author":"T Bisogno","year":"2001","unstructured":"Bisogno T, Hanus L, De Petrocelis L, Tehilibon S, Ponde DE, Brandi I, Moriello AS, Davies JB, Mechoulam R, Di Marzo V (2001) Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134:845\u2013852","journal-title":"Br J Pharmacol"},{"key":"868_CR3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11065-005-6252-y","volume":"15","author":"JS Bloom","year":"2005","unstructured":"Bloom JS, Hynd GW (2005) The role of the corpus callosum in interhemispheric transfer of information: excitation or inhibition? Neuropsychol Rev 15:59\u201371","journal-title":"Neuropsychol Rev"},{"key":"868_CR4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.2044-8341.1974.tb02285.x","volume":"47","author":"A Bond","year":"1974","unstructured":"Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211\u2013218","journal-title":"Br J Med Psychol"},{"key":"868_CR5","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1021\/tx9800598","volume":"11","author":"LM Bornheim","year":"1998","unstructured":"Bornheim LM, Grillo MP (1998) Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator. Chem Res Toxicol 11:1209\u20131216","journal-title":"Chem Res Toxicol"},{"key":"868_CR6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/mol.60.1.155","volume":"60","author":"CS Breivogel","year":"2001","unstructured":"Breivogel CS, Griffin G, Di Marzo V, Martin BR (2001) Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 60:155\u2013163","journal-title":"Mol Pharmacol"},{"key":"868_CR7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00001756-199803090-00020","volume":"9","author":"PK Chan","year":"1998","unstructured":"Chan PK, Chan SC, Yung WH (1998) Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist. Neuroreport 9:671\u2013675","journal-title":"Neuroreport"},{"key":"868_CR8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0165-1781(89)90053-X","volume":"29","author":"TJ Crow","year":"1989","unstructured":"Crow TJ, Colter N, Frith CD, Johnstone EC, Owens DGC (1989) Developmental arrest of cerebral asymmetries in early onset schizophrenia. Psychiatry Res 29:247\u2013253","journal-title":"Psychiatry Res"},{"key":"868_CR9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","volume":"103","author":"B Dean","year":"2001","unstructured":"Dean B, Sundram S, Bradbury R, Scarr E, Copolov D (2001) Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience 103:9\u201315","journal-title":"Neuroscience"},{"key":"868_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(89)80087-7","volume":"34","author":"RW Doty","year":"1989","unstructured":"Doty RW (1989) Schizophrenia: a disease of interhemispheric processes at forebrain and brainstem levels? Behav Brain Res 34:1\u201333","journal-title":"Behav Brain Res"},{"key":"868_CR11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0074-7742(06)78010-2","volume":"78","author":"DC D\u2019Souza","year":"2007","unstructured":"D\u2019Souza DC (2007) Cannabinoids and psychosis. Int Rev Neurobiol 78:289\u2013326","journal-title":"Int Rev Neurobiol"},{"key":"868_CR12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0091-3057(96)00426-1","volume":"56","author":"HM Emrich","year":"1997","unstructured":"Emrich HM, Leweke FM, Schneider U (1997) Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacol Biochem Behav 56:803\u2013807","journal-title":"Pharmacol Biochem Behav"},{"key":"868_CR13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-1781(99)00027-X","volume":"86","author":"L Flyckt","year":"1999","unstructured":"Flyckt L, Sydow O, Bjerkenstedt L, Edman G, Rydin E, Wiesel FA (1999) Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls. Psychiatry Res 86:113\u2013129","journal-title":"Psychiatry Res"},{"key":"868_CR14","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1176\/ajp.156.9.1342","volume":"156","author":"S Gold","year":"1999","unstructured":"Gold S, Arndt S, Nopoulos P, O\u2019Leary DS, Andreasen NC (1999) Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am J Psychiatry 156:1342\u20131348","journal-title":"Am J Psychiatry"},{"key":"868_CR15","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/jnnp.51.5.626","volume":"51","author":"DJ Goode","year":"1988","unstructured":"Goode DJ, Manning AA (1988) Specific imbalance of right and left sided motor neuron excitability in schizophrenia. J Neurol Neurosurg Psychiatry 51:626\u2013629","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"868_CR16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0165-1781(81)90071-8","volume":"5","author":"DJ Goode","year":"1981","unstructured":"Goode DJ, Manning AA, Middleton JF, Williams B (1981) Fine motor performance before and after treatment in schizophrenic and schizoaffective patients. Psychiatry Res 5:247\u2013255","journal-title":"Psychiatry Res"},{"key":"868_CR17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00406-003-0409-6","volume":"253","author":"I Gorynia","year":"2003","unstructured":"Gorynia I, Campman V, Uebelhack R (2003) Intermanual coordination in relation to different clinical subgroups in right-handed patients with schizophrenic and other psychotic disorders. Eur Arch Psychiatry Clin Neurosci 253:53\u201359","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"868_CR18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02279809","volume":"244","author":"I Gorynia","year":"1994","unstructured":"Gorynia I, Dudeck U, Neum\u00e4rker KJ (1994) Instability in functional motor laterality of children and adolescents with endogenous psychosis and predominantly motor disturbances. Eur Arch Psychiatry Clin Neurosci 244:33\u201338","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"868_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-9452(08)70832-3","volume":"36","author":"I Gorynia","year":"2000","unstructured":"Gorynia I, Egenter D (2000) Intermanual coordination in relation to handedness, familial sinistrality and lateral preferences. Cortex 36:1\u201318","journal-title":"Cortex"},{"key":"868_CR20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02190341","volume":"242","author":"I Gorynia","year":"1992","unstructured":"Gorynia I, Uebelhack R (1992) Functional motor asymmetries correlated with clinical findings in unmedicated schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 242:39\u201345","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"868_CR21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/156800705774322111","volume":"4","author":"F Grotenhermen","year":"2005","unstructured":"Grotenhermen F (2005) Cannabinoids. Curr Drug Targets CNS Neurol Disord 4:507\u2013530","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"868_CR22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00515918","volume":"235","author":"W G\u00fcnther","year":"1986","unstructured":"G\u00fcnther W, G\u00fcnther R, Eich FX, Eben E (1986) Psychomotor disturbances in psychiatric patients as a possible basis for new attempts at differential diagnosis and therapy. II. Cross validation study on schizophrenic patients: persistence of a \u201cpsychotic motor syndrome\u201d as possible evidence of an independent biological marker syndrome for schizophrenia. Eur Arch Psychiatry Neurol Sci 235:301\u2013308","journal-title":"Eur Arch Psychiatry Neurol Sci"},{"key":"868_CR23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1176\/ajp.152.2.191","volume":"152","author":"S Gupta","year":"1995","unstructured":"Gupta S, Andreasen NC, Arndt S, Flaum M, Schultz SK, Hubbard WC, Smith M (1995) Neurological soft signs in neuroleptic-naive and neuroleptic treated schizophrenic patients and in normal comparison subjects. Am J Psychiatry 152:191\u2013196","journal-title":"Am J Psychiatry"},{"key":"868_CR24","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","volume":"87","author":"M Herkenham","year":"1990","unstructured":"Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932\u20131936","journal-title":"Proc Natl Acad Sci USA"},{"key":"868_CR25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0925-4927(95)02729-H","volume":"61","author":"H Hokama","year":"1995","unstructured":"Hokama H, Shenton ME, Nestor PG, Kikinis R, Levitt JJ, Metcalf D, Wible CG, O\u2019Donnell BF, Jolesz FA, McCarley RW (1995) Caudate, putamen, and globus pallidus volume in schizophrenia: a quantitative MRI study. Psychiatry Res 61:209\u2013229","journal-title":"Psychiatry Res"},{"key":"868_CR26","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/awg143","volume":"126","author":"L Iversen","year":"2003","unstructured":"Iversen L (2003) Cannabis and the brain. Brain 126:1252\u2013 1270","journal-title":"Brain"},{"key":"868_CR27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1192\/bjp.178.2.116","volume":"178","author":"A Johns","year":"2001","unstructured":"Johns A (2001) Psychiatric effects of cannabis. Br J Psychiatry 178:116\u2013122","journal-title":"Br J Psychiatry"},{"key":"868_CR28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.schres.2007.08.015","volume":"97","author":"G Juckel","year":"2007","unstructured":"Juckel G, Roser P, Nadulski T, Stadelmann AM, Gallinat J (2007) Acute effects of delta-9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity. Schizophr Res 97:109\u2013117","journal-title":"Schizophr Res"},{"key":"868_CR29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2466\/pms.1985.61.2.479","volume":"61","author":"SE Levander","year":"1985","unstructured":"Levander SE, Bartfai A, Schalling D (1985) Regional cortical dysfunction in schizophrenic patients studied by computerized neuropsychological methods. Percept Mot Skills 61:479\u2013495","journal-title":"Percept Mot Skills"},{"key":"868_CR30","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/00001756-199906030-00008","volume":"10","author":"FM Leweke","year":"1999","unstructured":"Leweke FM, Giuffrida A, Wurster U, Emrich HM, Piomelli D (1999) Elevated endogenous cannabinoids in schizophrenia. Neuroreport 10:1665\u20131669","journal-title":"Neuroreport"},{"key":"868_CR31","volume-title":"Neuropsychological assessments","author":"MD Lezak","year":"1995","unstructured":"Lezak MD (1995) Neuropsychological assessments, 3rd edn. Oxford University Press, New York","edition":"3"},{"key":"868_CR32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1192\/bjp.164.5.679","volume":"164","author":"MJ Martinez-Arevalo","year":"1994","unstructured":"Martinez-Arevalo MJ, Calcedo-Ordonez A, Varo-Prieto JR (1994) Cannabis consumption as a prognostic factor in schizophrenia. Br J Psychiatry 164:679\u2013681","journal-title":"Br J Psychiatry"},{"key":"868_CR33","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561\u2013564","journal-title":"Nature"},{"key":"868_CR34","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1021\/ja01092a065","volume":"87","author":"R Mechoulam","year":"1965","unstructured":"Mechoulam R, Gaoni Y (1965) A total synthesis of delta-1-tetrahydrocannabinol, the active constituent of hashish. J Am Chem Soc 87:3273\u20133275","journal-title":"J Am Chem Soc"},{"key":"868_CR35","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","volume":"42","author":"R Mechoulam","year":"2002","unstructured":"Mechoulam R, Parker LA, Gallily R (2002) Cannabidiol: an overview of some pharmacological aspects. J Clin Pharmacol 42:11S\u201319S","journal-title":"J Clin Pharmacol"},{"key":"868_CR36","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/01.ftd.0000177223.19294.5c","volume":"27","author":"T Nadulski","year":"2005","unstructured":"Nadulski T, Pragst F, Weinberg G, Roser P, Schnelle M, Fronk EM, Stadelmann AM (2005) Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract. Ther Drug Monit 27:799\u2013810","journal-title":"Ther Drug Monit"},{"key":"868_CR37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0028-3932(71)90067-4","volume":"9","author":"RC Oldfield","year":"1971","unstructured":"Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97\u2013113","journal-title":"Neuropsychologia"},{"key":"868_CR38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1001\/archneur.58.1.105","volume":"58","author":"J Pelletier","year":"2001","unstructured":"Pelletier J, Suchet L, Witjas T, Habib M, Guttmann CR, Salamon G, Lyon-Caen O, Ch\u00e9rif AA (2001) A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. Arch Neurol 58:105\u2013111","journal-title":"Arch Neurol"},{"key":"868_CR39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"RG Pertwee","year":"2008","unstructured":"Pertwee RG (2008) The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin. Br J Pharmacol 153:199\u2013215","journal-title":"Br J Pharmacol"},{"key":"868_CR40","first-page":"1","volume-title":"Neuromethods, vol 13: psychopharmacology","author":"CJ Pycock","year":"1989","unstructured":"Pycock CJ, Kilpatric IC (1989) Motor asymmetries and drug effects: behavioral analyses of receptor activation. In: Boulton AA, Baker GB, Greenshaw AJ (eds) Neuromethods, vol 13: psychopharmacology. Human Press, Clifton, pp 1\u201393"},{"key":"868_CR41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1006\/nbdi.1998.0217","volume":"5","author":"F Rodriguez de Fonseca","year":"1998","unstructured":"Rodriguez de Fonseca F, Del Arco I, Martin-Calderon JL, Gorriti MA, Navarro M (1998) Role of the endogenous cannabinoid system in the regulation of motor activity. Neurobiol Dis 5:483\u2013501","journal-title":"Neurobiol Dis"},{"key":"868_CR42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF03033228","volume":"3","author":"F Rodriguez de Fonseca","year":"2001","unstructured":"Rodriguez de Fonseca F, Gorriti MA, Bilbao A, Escuredo L, Garcia-Segura LM, Piomelli D, Navarro M (2001) Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson\u2019s disease and schizophrenia. Neurotox Res 3:23\u201335","journal-title":"Neurotox Res"},{"key":"868_CR43","doi-asserted-by":"crossref","unstructured":"Roser P, Vollenweider FX, Kawohl W (2008) Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists. World J Biol Psychiatry 7:1\u201312. DOI: 10.1080\/15622970801908047","DOI":"10.1080\/15622970801908047"},{"key":"868_CR44","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.euroneuro.2008.04.008","volume":"18","author":"P Roser","year":"2008","unstructured":"Roser P, Juckel G, Rentzsch J, Nadulski T, Gallinat J, Stadelmann AM (2008) Effects of acute oral Delta(9)-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers. Eur Neuropsychopharmacol 18:569\u2013577","journal-title":"Eur Neuropsychopharmacol"},{"issue":"Suppl 1","key":"868_CR45","first-page":"256","volume":"11","author":"P Roser","year":"2008","unstructured":"Roser P, Stadelmann AM, Arning L, Gallinat J, Epplen JT, Juckel G (2008) Acute effects of \u03949-tetrahydrocannabinol on the auditory event-related mismatch negativity depending on genetic variations in the dysbindin, neuregulin and G72 gene. Int J Neuropsychopharmacol 11(Suppl 1):256","journal-title":"Int J Neuropsychopharmacol"},{"key":"868_CR46","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","volume":"152","author":"E Ryberg","year":"2007","unstructured":"Ryberg E, Larsson N, Sj\u00f6gren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ (2007) The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152:1092\u20131101","journal-title":"Br J Pharmacol"},{"key":"868_CR47","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0014-2999(00)00044-3","volume":"391","author":"MC Sa\u00f1udo-Pe\u00f1a","year":"2000","unstructured":"Sa\u00f1udo-Pe\u00f1a MC, Romero J, Seale GE, Fernandez-Ruiz JJ, Walker JM (2000) Activational role of cannabinoids on movement. Eur J Pharmacol 391:269\u2013274","journal-title":"Eur J Pharmacol"},{"key":"868_CR48","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0024-3205(99)00293-3","volume":"65","author":"MC Sa\u00f1udo-Pe\u00f1a","year":"1999","unstructured":"Sa\u00f1udo-Pe\u00f1a MC, Tsou K, Walker JM (1999) Motor actions of cannabinoids in the basal ganglia output nuclei. Life Sci 65:703\u2013713","journal-title":"Life Sci"},{"key":"868_CR49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0166-4328(94)90135-X","volume":"64","author":"HC Sauerwein","year":"1994","unstructured":"Sauerwein HC, Lassonde M (1994) Cognitive and sensori-motor functioning in the absence of the corpus callosum: neuropsychological studies in callosal agenesis and callosotomized patients. Behav Brain Res 64:229\u2013240","journal-title":"Behav Brain Res"},{"key":"868_CR50","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0028-3932(99)00120-7","volume":"38","author":"SL Schmidt","year":"2000","unstructured":"Schmidt SL, Oliveira RM, Krahe TE, Filgueiras CC (2000) The effects of hand preference and gender on finger tapping performance asymmetry by the use of an infra-red light measurement device. Neuropsychologia 38:529\u2013534","journal-title":"Neuropsychologia"},{"key":"868_CR51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/00221309.1936.9917905","volume":"15","author":"D Shakow","year":"1936","unstructured":"Shakow D, Huston PE (1936) Studies on motor function in schizophrenia: I. Speed of tapping. J Gen Psychol 15:63\u2013106","journal-title":"J Gen Psychol"},{"key":"868_CR52","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S0033291700050911","volume":"13","author":"JC Shaw","year":"1983","unstructured":"Shaw JC, Colter N, Resek G (1983) EEG coherence, lateral preference and schizophrenia. Psychol Med 13:299\u2013306","journal-title":"Psychol Med"},{"key":"868_CR53","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archneur.1990.00530060095025","volume":"47","author":"I Shimoyama","year":"1990","unstructured":"Shimoyama I, Ninchoji T, Uemura K (1990) The finger-tapping test. A quantitative analysis. Arch Neurol 47:681\u2013684","journal-title":"Arch Neurol"},{"key":"868_CR54","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511526824","volume-title":"Cannabis and cognitive functioning","author":"N Solowij","year":"1998","unstructured":"Solowij N (1998) Cannabis and cognitive functioning. Cambridge University Press, Cambridge"},{"key":"868_CR55","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0006-3223(89)90175-3","volume":"25","author":"P Stratta","year":"1989","unstructured":"Stratta P, Rossi A, Gallucci M, Amicarelli I, Passariello R, Casacchia M (1989) Hemispheric asymmetries and schizophrenia: a preliminary magnetic resonance imaging study. Biol Psychiatry 25:275\u2013284","journal-title":"Biol Psychiatry"},{"issue":"Suppl 5","key":"868_CR56","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00406-008-5016-0","volume":"258","author":"W Strik","year":"2008","unstructured":"Strik W, Dierks T (2008) Neurophysiological mechanisms of psychotic symptoms. Eur Arch Psychiatry Clin Neurosci 258(Suppl 5):66\u201370","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"868_CR57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/155005949402500207","volume":"25","author":"FA Struve","year":"1994","unstructured":"Struve FA, Straumanis JJ, Patrick G (1994) Persistent topographic quantitative EEG sequelae of chronic marihuana use: a replication study and initial discriminant function analysis. Clin Electroencephalogr 25:63\u201375","journal-title":"Clin Electroencephalogr"},{"key":"868_CR58","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0376-8716(99)00029-0","volume":"56","author":"FA Struve","year":"1999","unstructured":"Struve FA, Straumanis JJ, Patrick G, Leavitt J, Manno JE, Manno BR (1999) Topographic quantitative EEG sequelae of chronic marihuana use: a replication using medically and psychiatrically screened normal subjects. Drug Alcohol Depend 56:167\u2013179","journal-title":"Drug Alcohol Depend"},{"key":"868_CR59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0306-4522(00)00036-1","volume":"97","author":"B Szabo","year":"2000","unstructured":"Szabo B, Wallmichrath I, Mathonia P, Pfreundtner C (2000) Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata. Neuroscience 97:89\u201397","journal-title":"Neuroscience"},{"key":"868_CR60","first-page":"381","volume":"15","author":"E Torrey","year":"1980","unstructured":"Torrey E (1980) Neurological abnormalities in schizophrenic patients. Biol Psychiatry 15:381\u2013388","journal-title":"Biol Psychiatry"},{"key":"868_CR61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/schbul\/16.1.87","volume":"16","author":"WM Turner","year":"1990","unstructured":"Turner WM, Tsuang MT (1990) Impact of substance abuse on the course and outcome of schizophrenia. Schizophr Bull 16:87\u201395","journal-title":"Schizophr Bull"},{"key":"868_CR62","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00406-006-0707-x","volume":"257","author":"T Wobrock","year":"2007","unstructured":"Wobrock T, Sittinger H, Behrendt B, D\u2019Amelio R, Falkai P, Caspari D (2007) Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 257:203\u2013210","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"868_CR63","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/jnnp.58.4.457","volume":"58","author":"PW Woodruff","year":"1995","unstructured":"Woodruff PW, McManus IC, David AS (1995) Meta-analysis of corpus callosum size in schizophrenia. J Neurol Neurosurg Psychiatry 58:457\u2013461","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"868_CR64","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pnpbp.2003.11.005","volume":"28","author":"K Zavitsanou","year":"2004","unstructured":"Zavitsanou K, Garrick T, Huang XF (2004) Selective antagonist [3H] SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28:355\u2013360","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-009-0868-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-009-0868-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-009-0868-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T01:43:03Z","timestamp":1684892583000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-009-0868-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,17]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["868"],"URL":"https:\/\/doi.org\/10.1007\/s00406-009-0868-5","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,17]]}}}